Experimental cancer drug OMX-0407 trial halted early
Disease control
Terminated
This early-phase trial tested OMX-0407, a new drug that blocks certain enzymes, in 68 adults with advanced solid tumors that had stopped responding to other treatments. The study aimed to find a safe dose and check if the drug could shrink tumors. However, the trial was terminate…
Phase: PHASE1, PHASE2 • Sponsor: iOmx Therapeutics AG • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC